Ceclazepide
Modify Date: 2025-09-18 17:36:14
Ceclazepide structure
|
Common Name | Ceclazepide | ||
|---|---|---|---|---|
| CAS Number | 1801749-44-9 | Molecular Weight | 556.612 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 773.4±60.0 °C at 760 mmHg | |
| Molecular Formula | C30H32N6O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 421.5±32.9 °C | |
Use of CeclazepideA potent, selective cholecystokinin receptor CCK2 antagonist for treatment of gastroesophageal reflux disease (GERD). Other Indication Phase 1 Clinical |
| Name | ceclazepide |
|---|---|
| Synonym | More Synonyms |
| Description | A potent, selective cholecystokinin receptor CCK2 antagonist for treatment of gastroesophageal reflux disease (GERD). Other Indication Phase 1 Clinical |
|---|---|
| References | References View Related Products by Target Cholecystokinin Receptor Other Indication |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 773.4±60.0 °C at 760 mmHg |
| Molecular Formula | C30H32N6O5 |
| Molecular Weight | 556.612 |
| Flash Point | 421.5±32.9 °C |
| Exact Mass | 556.243408 |
| LogP | 3.16 |
| Vapour Pressure | 0.0±2.7 mmHg at 25°C |
| Index of Refraction | 1.633 |
| InChIKey | GPEYTRIZYSZRRK-MHZLTWQESA-N |
| SMILES | CNc1cccc(NC(=O)NC2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(C)(C)COC(C)=O)C2=O)c1 |
| 99B5ZR9276 |
| 2,2-Dimethyl-4-[(3R)-3-({[3-(methylamino)phenyl]carbamoyl}amino)-2-oxo-5-(2-pyridinyl)-2,3-dihydro-1H-1,4-benzodiazepin-1-yl]-3-oxobutyl acetate |
| ceclazepide |
| Urea, N-[(3R)-1-[4-(acetyloxy)-3,3-dimethyl-2-oxobutyl]-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]- |